ICL Israel Chemicals Ltd (ICL) Stock Forecast & Price Target
ICL Israel Chemicals Ltd · NYSE
$5.23+0.08 (+1.55%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering ICL Israel Chemicals Ltd, 0 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $7.00 to $7.00, so the covering firms are broadly aligned. The average target of $7.00 sits 34% above the current $5.23. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.11 next quarter toward $0.45 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Hold
Strong Buy00%
Buy00%
Hold1100%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to ICL Israel Chemicals Ltd.
As of Jul, 0 of 1 firms rate ICL a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ICL EPS & revenue forecast
EPS · NEXT QUARTER
$0.11
Range $0.10 – $0.11 · 4 analysts · +6% YoY
Next period, 4 analysts expect ICL Israel Chemicals Ltd to earn $0.11 a share (range $0.10 – $0.11), versus $0.10 a year earlier. Full-year consensus is $0.42, growing to $0.45 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 4 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $7.8B, rising to $8.0B next year.
Top analysts covering ICL Israel Chemicals Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ICL.
#1
Benjamin Theurer
Barclays · Rank #72
Hold
$7.00+33.8% to target
Overall win rate
47%
+ Follow
#2
Joel Jackson
BMO Capital
Hold
$6.00+14.7% to target
Coverage
—
+ Follow
#3
ND
Nigel Dally
Morgan Stanley
Hold
$6.20+18.5% to target
Coverage
—
+ Follow
ICL stock forecast FAQ
What is ICL's average 12-month price target?+
The 1 analysts with a live target average $7.00 for ICL Israel Chemicals Ltd over the next 12 months, ranging from a $7.00 high to a $7.00 low.
Is ICL stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 1 analyst ratings, 0 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover ICL?+
1 analysts have an active rating on ICL Israel Chemicals Ltd, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering ICL?+
Among analysts who currently cover ICL, Benjamin Theurer of Barclays has the strongest overall Quantellect track record (Rank #72). Their current call is Hold with a $7.00 target.
What is ICL Israel Chemicals Ltd's projected EPS for next quarter?+
The consensus estimate is $0.11 per share (range $0.10 – $0.11) across 4 analysts. Full-year EPS is projected at $0.42, rising to $0.45 the following year.
How much revenue is ICL Israel Chemicals Ltd expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $7.8B, growing to $8.0B next year.
Have analysts been upgrading or downgrading ICL lately?+
As of Jul, 0 of 1 firms rate ICL a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ICL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
